Kodak’s top official is talking about the status of the company’s potential federal loan, a deal which has created a lot of controversy in recent days.
Executive Chairman Jim Continenza made a few brief comments about the potential loan during the company’s second-quarter earnings conference call on Tuesday.
The $765 million loan, announced two weeks ago, would help Kodak gear up to make ingredients used in generic drugs.